Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer

Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer

Show other versions (1)

Bibliographic Details
Main Authors:	Kazushi Inoue, Elizabeth A. Fry
Format:	Article
Language:	English
Published:	SAGE Publishing 2015-12-01
Series:	Genetics and Epigenetics
Online Access:	http://www.la-press.com/aberrant-splicing-of-estrogen-receptor-her2-and-cd44-genes-in-breast-c-article-a5241

Similar Items

Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
by: Kazushi Inoue, et al.
Published: (2015-01-01)

WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells.
by: Wen Jiang, et al.
Published: (2013-01-01)

Estrogen-Related Receptors in Breast Cancer and Prostate Cancer
by: Satoshi eInoue, et al.
Published: (2015-05-01)

Effect of CD44st and HER2 expression on the postoperative prognosis of breast cancer patients
by: Chen DD, et al.
Published: (2019-01-01)

A correlation study of the expression of HA-CD44st and HER-2 in breast cancer
by: Ying Zhi L, et al.
Published: (2018-09-01)

Status of estrogene, progesterone receptors and HER-2/neu expression in invasive breast cancer
by: Naghshvar F, et al.
Published: (2007-01-01)

Role of Estrogen Receptor, Progesterone Receptor and HER2/neu Expression in Breast Carcinoma SubtypingRole of Estrogen Receptor, Progesterone Receptor and HER2/neu Expression in Breast Carcinoma Subtyping
by: Tummidi Santosh, et al.
Published: (2021-01-01)

Her2 is important to androgen receptor expression and phosphorylation in estrogen receptor negative breast cancer cells
by: Chen-Chuan Huang, et al.
Published: (2012)

HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?
by: Atul Batra, et al.
Published: (2021-02-01)

TDP43 promotes stemness of breast cancer stem cells through CD44 variant splicing isoforms
by: Guo, L., et al.
Published: (2022)

Concordance between Immunohistochemistry and Microarray Gene Expression Profiling for Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Statuses in Breast Cancer Patients in Lebanon
by: Ghina B. Fakhri, et al.
Published: (2018-01-01)

Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients
by: Nick Beije, et al.
Published: (2018-01-01)

Cosmc Disruption-Mediated Aberrant O-glycosylation Suppresses Breast Cancer Cell Growth via Impairment of CD44
by: Du T, et al.
Published: (2020-01-01)

Elevated expression of CD151 gene in estrogen receptor and progesterone receptor positive breast carcinoma
by: Ivyna Bong PN, et al.
Published: (2011)

Downregulation of CD44 reduces doxorubicin resistance of CD44+CD24- breast cancer cells
by: Phuc PV, et al.
Published: (2011-06-01)

Genes dysregulated to different extent or oppositely in estrogen receptor-positive and estrogen receptor-negative breast cancers.
by: Xianxiao Zhou, et al.
Published: (2013-01-01)

SALL4 - KHDRBS3 network enhances stemness by modulating CD44 splicing in basal-like breast cancer
by: Matsumoto, Yoshiaki
Published: (2018)

Expression of CD44 in human breast cancer
by: Sidorchuk, Janine
Published: (2007)

Expression of CD44 in human breast cancer
by: Sidorchuk, Janine
Published: (2007)

Expression of CD44 in human breast cancer
by: Sidorchuk, Janine
Published: (2007)

Expression of autophagy-related proteins according to androgen receptor and HER-2 status in estrogen receptor-negative breast cancer.
by: Ji-Ye Kim, et al.
Published: (2014-01-01)

Role of Aberrant Alternative Splicing in Cancer
by: Milad Khorasani, et al.
Published: (2021-06-01)

Towards the molecular diagnosis of bladder and colorectal cancer : analysis of CD44 exon splicing
by: Morgan, Sarah Louise
Published: (2002)

Estrogen Receptor and HER2 Status on Disseminated Tumor Cells and Primary Tumor in Patients with Early Breast Cancer
by: Bernadette A.S. Jäger, et al.
Published: (2015-12-01)

Direct estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer.
by: Denis Collins, et al.
Published: (2017-01-01)

Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor-directed therapies
by: Nayar, Utthara, et al.
Published: (2020)

Tumour promoting HER2 splice variant 16HER2 : regulation and implication in breast cancer
by: Dittrich, Anna-Lena
Published: (2017)

Aberrant miRNAs expressed in HER-2 negative breast cancers patient
by: Cornelia Braicu, et al.
Published: (2018-10-01)

The expression of the transmembrane glycoprotein in CD44 in breast cancer
by: Bolodeoku, John Adekunle
Published: (1996)

Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer
by: Koji Kitamura, et al.
Published: (2021-04-01)

Promoter Hypermethylation of Estrogen Receptor Alpha Gene Is Correlated to Estrogen Receptor Negativity in Iranian Patients with Sporadic Breast Cancer
by: Mohammad Taghi Akbari, et al.
Published: (2012-01-01)

Gene expression signature of estrogen receptor α status in breast cancer
by: Baggerly Keith, et al.
Published: (2005-03-01)

Aberrant RNA Splicing in Cancer and Drug Resistance
by: Bi-Dar Wang, et al.
Published: (2018-11-01)

Aberrant Alternative Splicing Is Another Hallmark of Cancer
by: Michael Ladomery
Published: (2013-01-01)

Defining regulation of Herstatin and novel HER2 splice variants in breast cancer
by: Silipo, Marco
Published: (2017)

Functional applications of CD44-splice variant expression in rheumatoid arthritis
by: Wibulwas, Auragan
Published: (2004)

Identification and Characterization of CD44RC, a Novel Alternatively Spliced Soluble CD44 Isoform that can Potentiate the Hyaluronan Binding Activity of Cell Surface CD44
by: Roland K. Chiu, et al.
Published: (1999-11-01)

Estrogen receptor beta and estrogen response in breast cancer cell lines
by: Stewart, Ceri Elisabeth
Published: (2008)

ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer
by: Marco La Ferla, et al.
Published: (2019-06-01)

Reply to Letter to Editor: “HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?”
by: Shuai Li, et al.
Published: (2021-02-01)

Cannot write session to /tmp/vufind_sessions/sess_9i2jdpajht996pcddch1opn3hv